Company Focus

Moderna

Latest Moderna News

FDA grants approval for Spikevax in young children
Biotechnology
The US Food and Drug Administration (FDA) has approved US mRNA specialist Moderna supplemental Biologics License Application (sBLA) for Spikevax, the company's COVID-19 vaccine, in children six months through 11 years of age who are at increased risk for COVID-19 disease.   11 July 2025


Latest News & Features of interest to Moderna

Latest Relevant Ones To Watch News

Theratechnologies, a Canada-based biopharma, is to be acquired by CB Biotechnology, an affiliate of Future Pak, a privately-held contract manufacturer, packager and distributor of pharmaceutical and nutraceutical products.   4 July 2025

More in M&A >


Relevant Ones to Watch Companies

Reset all filters
Refine Search